<DOC>
	<DOC>NCT00474760</DOC>
	<brief_summary>This is a phase 1 study of anti-IGF-IR CP-751,871 in patients with solid tumors currently enrolling patients 9 years old and older with Ewing's sarcoma family of tumors (Ewing's, PNET and Askin's).</brief_summary>
	<brief_title>Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma, Ewing</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Diagnosis of Ewing's sarcoma family tumors Concurrent treatment with any other anti tumor agents</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>